Reviewing the Rationale for Cross-Shareholdings and the Sale Policy
First written in FY2019. 12 of 13 entries say "Advanced", first in FY2020. Latest entry: FY2024.
- FY2024AdvancedAnnual report
「During the fiscal year under review, the number of shares declined for 1 issue of unlisted shares, and the total sale price associated with the decline in the number of shares was ¥228 million.」
The company reviewed the rationale for its holdings annually and sold 1 issue of unlisted shares for ¥228 million. A gain on sale of ¥226 million was also recorded. - FY2024-Q2AdvancedAnnual report
「At a Board of Directors meeting held on 20 September 2023, the company resolved to sell an investment security it held, namely 1 issue of unlisted shares, and sold it as described below.」
As a result of implementing the policy on strategic shareholdings, 1 issue of unlisted shares was sold for ¥228 million on 3 October 2023, and the company planned to record a gain on sale of ¥226 million. - FY2023AdvancedAnnual report
「During the fiscal year under review, the number of shares declined for 1 issue other than unlisted shares, and the total sale price associated with the decline in the number of shares was ¥23.737 million.」
Under the policy of reviewing the economic rationale and significance of holdings annually at Board of Directors meetings, 1 issue was sold, generating sale proceeds of ¥23.737 million. - FY2023-Q3AdvancedAnnual report
「This was mainly due to a ¥36.252 million decrease in investment securities resulting from sales and changes in fair value.」
In relation to the review of the rationale for strategic shareholdings and the policy of selling them, investment securities decreased by ¥36.252 million due to sales and changes in fair value. - FY2023-Q2AdvancedAnnual report
「Cash flows from investing activities decreased by ¥41.474 million, compared with a decrease of ¥217.335 million in the same quarter of the previous year. This was mainly because, while payments for the acquisition of new processing equipment and other assets amounted to ¥65.224 million, proceeds from the sale of investment securities amounted to ¥23.737 million.」
Proceeds of ¥23.737 million from the sale of investment securities were recorded as a transaction related to the review of the rationale for strategic shareholdings and the policy of selling them. - FY2023-Q1AdvancedAnnual report
「This was due to a ¥20.683 million decrease in investment securities resulting from sales and other factors, leaving a balance of ¥145.912 million.」
In relation to the review of the rationale for strategic shareholdings and the policy of selling them, investment securities decreased by ¥20.683 million due to sales and other factors. - FY2022AdvancedAnnual report
「During the fiscal year under review, the number of shares declined for 1 issue other than unlisted shares, and the total sale price associated with the decline in the number of shares was ¥17.515 million.」
The company disclosed a sale of 1 issue other than unlisted shares as part of its practice of reviewing the rationale for strategic shareholdings annually. - FY2021AdvancedAnnual report
「During the fiscal year under review, the number of shares declined for 1 issue other than unlisted shares, and the total sale price associated with the decline in the number of shares was ¥53.229 million.」
Under the policy of reviewing the rationale for strategic shareholdings annually, 1 issue other than unlisted shares was sold, generating sale proceeds of ¥53.229 million. - FY2021-Q3AdvancedAnnual report
「Fixed assets totaled ¥1,105.828 million, a decrease of ¥41.644 million from the end of the previous fiscal year. This was because property, plant and equipment increased by ¥12.540 million, while investment securities under investments and other assets decreased by ¥54.988 million due to the sale of held shares.」
As a transaction related to the review of the rationale for strategic shareholdings and the policy of selling them, investment securities decreased by ¥54.988 million following the sale of held shares. The reasons for the sale are not detailed in this filing. - FY2021-Q2AdvancedAnnual report
「Net cash provided by investing activities increased by ¥110.013 million, compared with a decrease of ¥5.648 million in the same quarter of the previous year. This was mainly because proceeds from the sale of investment securities totaled ¥120.379 million, while expenditure for the acquisition of property, plant and equipment amounted to ¥9.280 million.」
Proceeds of ¥120.379 million from the sale of investment securities were recorded as a transaction related to the review of the rationale for strategic shareholdings and the policy of selling them. - FY2021-Q1AdvancedAnnual report
「Property, plant and equipment and other fixed assets totaled ¥1,095.608 million, a decrease of ¥51.863 million from the end of the previous fiscal year. This was mainly due to a ¥52.779 million decrease in investment securities included in investments and other assets, resulting from the sale of held shares.」
Investment securities decreased by ¥52.779 million following the sale of held shares, adding a record of sales of strategic shareholdings. The filing does not indicate a direct connection between the reasons for the sales and the review of their rationale. - FY2020AdvancedAnnual report
「During the fiscal year under review, the number of shares declined for 2 issues other than unlisted shares, and the total sale price associated with the decline in the number of shares was ¥19.848 million.」
For strategic shareholdings, 2 issues other than unlisted shares were sold, generating total sale proceeds of ¥19.848 million. - FY2019First statedAnnual report
「We hold shares in companies deemed necessary to maintain and strengthen business relationships and facilitate the smooth execution of our businesses. The Board of Directors seeks to minimize the risks of such strategic shareholdings by periodically or as needed reviewing their medium- to long-term economic rationale and relationships with the investee companies. We will appropriately sell any holdings whose significance or rationale is determined not to be justified.」
For strategic shareholdings, the company explicitly stated for the first time its policy of reviewing relationships with investee companies and their medium- to long-term economic rationale, and selling the holdings when their rationale is not justified.